March 26, 2013, New York, NY—Three Ludwig scientists were named as Fellows in the inaugural class of the AACR Academy, the most prestigious honor bestowed by the American Association for Cancer Research.
The first class of Fellows includes Webster K. Cavenee, PhD, Director, Ludwig Institute for Cancer Research at the University of California San Diego; Bert Vogelstein, MD, Director, Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins University; and Robert A. Weinberg, PhD, Director, Ludwig/MIT Center for Molecular Oncology.
“Each of these researchers has pioneered advancements in cancer research. They have helped to transform the landscape by enhancing the understanding of the underlying causes of cancer and accelerating the development of new tools to defeat it,” said Edward A. McDermott, Jr., President and Chief Executive Officer, Ludwig Institute for Cancer Research. “We are grateful for the recognition by AACR of the life work of these researchers.”
The 106 Fellows who comprise the inaugural class were selected by their peers for their extraordinary contributions to the cancer field and will be inducted on April 5, 2013. The AACR Academy was created to recognize and honor distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer.
About the Ludwig Institute for Cancer Research
The Ludwig Institute is an international non-profit organization committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for patient benefit. Since its establishment in 1971, the Institute has spent more than $1.5 billion on cancer research.
About the Ludwig Centers
The Ludwig Centers, located at six leading U.S. academic institutions, are laboratories dedicated to cancer research. The Centers were endowed by the Virginia and D.K. Ludwig Fund for Cancer Research.